699 related articles for article (PubMed ID: 31834594)
1. The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.
Defendi F; Thielens NM; Clavarino G; Cesbron JY; Dumestre-Pérard C
Clin Rev Allergy Immunol; 2020 Apr; 58(2):229-251. PubMed ID: 31834594
[TBL] [Abstract][Full Text] [Related]
2. Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.
Corvillo F; Okrój M; Nozal P; Melgosa M; Sánchez-Corral P; López-Trascasa M
Front Immunol; 2019; 10():886. PubMed ID: 31068950
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against complement components and functional consequences.
Dragon-Durey MA; Blanc C; Marinozzi MC; van Schaarenburg RA; Trouw LA
Mol Immunol; 2013 Dec; 56(3):213-21. PubMed ID: 23790637
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies Against C3b-Functional Consequences and Disease Relevance.
Vasilev VV; Radanova M; Lazarov VJ; Dragon-Durey MA; Fremeaux-Bacchi V; Roumenina LT
Front Immunol; 2019; 10():64. PubMed ID: 30761135
[TBL] [Abstract][Full Text] [Related]
5. Complement activation by autoantigen recognition in the growth process of benign prostatic hyperplasia.
Hata J; Machida T; Matsuoka K; Hoshi S; Akaihata H; Hiraki H; Suzuki T; Ogawa S; Kataoka M; Haga N; Ishibashi K; Homma Y; Sekine H; Kojima Y
Sci Rep; 2019 Dec; 9(1):20357. PubMed ID: 31889151
[TBL] [Abstract][Full Text] [Related]
6. Complement analysis 2016: Clinical indications, laboratory diagnostics and quality control.
Prohászka Z; Nilsson B; Frazer-Abel A; Kirschfink M
Immunobiology; 2016 Nov; 221(11):1247-58. PubMed ID: 27475991
[TBL] [Abstract][Full Text] [Related]
7. Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses.
Murugaiah V; Varghese PM; Beirag N; De Cordova S; Sim RB; Kishore U
Viruses; 2021 May; 13(5):. PubMed ID: 34063241
[TBL] [Abstract][Full Text] [Related]
8. Anti-C1q autoantibodies.
Kallenberg CG
Autoimmun Rev; 2008 Sep; 7(8):612-5. PubMed ID: 18606253
[TBL] [Abstract][Full Text] [Related]
9. Complement in autoimmune diseases.
Vignesh P; Rawat A; Sharma M; Singh S
Clin Chim Acta; 2017 Feb; 465():123-130. PubMed ID: 28040558
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL
Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies Targeting Intracellular and Extracellular Proteins in Autoimmunity.
Burbelo PD; Iadarola MJ; Keller JM; Warner BM
Front Immunol; 2021; 12():548469. PubMed ID: 33763057
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against components of the classical pathway of complement.
Heinz HP; Loos M
Complement Inflamm; 1989; 6(3):166-74. PubMed ID: 2472920
[TBL] [Abstract][Full Text] [Related]
13. Molecules Great and Small: The Complement System.
Mathern DR; Heeger PS
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
[TBL] [Abstract][Full Text] [Related]
14. A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
Veszeli N; Füst G; Csuka D; Trauninger A; Bors L; Rozsa C; Nagy Z; Jobbágy Z; Eizler K; Prohászka Z; Varga L; Illes Z
Mol Immunol; 2014 Feb; 57(2):200-9. PubMed ID: 24172223
[TBL] [Abstract][Full Text] [Related]
15. Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.
Dijkstra DJ; van de Bovenkamp FS; Abendstein L; Zuijderduijn R; Pool J; Kramer CSM; Slot LM; Drijfhout JW; de Vor L; Gelderman KA; Rooijakkers SHM; Zaldumbide A; Vidarsson G; Sharp TH; Parren PWHI; Trouw LA
Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2310666120. PubMed ID: 38048459
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
Józsi M; Reuter S; Nozal P; López-Trascasa M; Sánchez-Corral P; Prohászka Z; Uzonyi B
Immunol Lett; 2014 Aug; 160(2):163-71. PubMed ID: 24491679
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
Holers VM
J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
[TBL] [Abstract][Full Text] [Related]
18. Detection of Autoantibodies to Complement Components by Surface Plasmon Resonance-Based Technology.
Noe R; Chauvet S; Togarsimalemath SK; Marinozzi MC; Radanova M; Vasilev VV; Fremeaux-Bacchi V; Dragon-Durey MA; Roumenina LT
Methods Mol Biol; 2019; 1901():271-280. PubMed ID: 30539587
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
Thanei S; Vanhecke D; Trendelenburg M
Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
[TBL] [Abstract][Full Text] [Related]
20. Role of collectins and complement protein C1q in pregnancy and parturition.
Madhukaran SP; Alhamlan FS; Kale K; Vatish M; Madan T; Kishore U
Immunobiology; 2016 Nov; 221(11):1273-88. PubMed ID: 27349595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
